Proteomic Analysis in Morquio A Cells Treated with Immobilized Enzymatic Replacement Therapy on Nanostructured Lipid Systems.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Sep 2019
Historique:
received: 22 08 2019
revised: 07 09 2019
accepted: 13 09 2019
entrez: 22 9 2019
pubmed: 22 9 2019
medline: 8 2 2020
Statut: epublish

Résumé

Morquio A syndrome, or mucopolysaccharidosis type IVA (MPS IVA), is a lysosomal storage disease due to mutations in the N-acetylgalactosamine-6-sulfatase (

Identifiants

pubmed: 31540344
pii: ijms20184610
doi: 10.3390/ijms20184610
pmc: PMC6769449
pii:
doi:

Substances chimiques

Lipids 0
Liposomes 0
Chondroitinsulfatases EC 3.1.6.-
GALNS protein, human EC 3.1.6.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Curr Pharm Biotechnol. 2011 Jun;12(6):931-45
pubmed: 21506915
Mol Genet Metab. 2012 Apr;105(4):542-50
pubmed: 22266136
J Proteome Res. 2017 Nov 3;16(11):4134-4143
pubmed: 28944677
Clin Chim Acta. 2011 Sep 18;412(19-20):1805-8
pubmed: 21684269
J Extracell Vesicles. 2017 May 26;6(1):1321455
pubmed: 28717418
Sci Rep. 2017 Jan 24;7:41191
pubmed: 28117408
Proteomics. 2014 May;14(10):1195-210
pubmed: 24723472
Expert Rev Clin Pharmacol. 2016 Dec;9(12):1521-1532
pubmed: 27855521
Res Vet Sci. 2018 Jun;118:449-465
pubmed: 29734122
Mol Cell Proteomics. 2007 Sep;6(9):1638-55
pubmed: 17533153
Proteomics. 2015 Aug;15(15):2597-601
pubmed: 25921073
Autophagy. 2012 May 1;8(5):719-30
pubmed: 22647656
EMBO Mol Med. 2016 Jan 19;8(2):73-6
pubmed: 26787653
Am J Med Genet A. 2015 Jan;167A(1):11-25
pubmed: 25346323
Clin Pharmacokinet. 2014 Dec;53(12):1137-47
pubmed: 25234648
EMBO J. 2010 Nov 3;29(21):3607-20
pubmed: 20871593
Mol Ther. 2010 Jun;18(6):1094-102
pubmed: 20332769
J Hum Genet. 2019 Jul;64(7):625-635
pubmed: 31019230
J Proteomics. 2019 Feb 20;193:217-229
pubmed: 30626528
Mol Genet Metab Rep. 2019 Jul 12;20:100487
pubmed: 31341787
Mol Genet Metab. 2018 Apr;123(4):479-487
pubmed: 29526614
Rev Esp Cardiol (Engl Ed). 2013 Aug;66(8):657-61
pubmed: 24776335
Mol Cell Proteomics. 2011 Jan;10(1):M110.003335
pubmed: 20807836
Gene Ther. 2003 Sep;10(18):1551-8
pubmed: 12907946
Expert Opin Orphan Drugs. 2015 Nov 1;3(11):1279-1290
pubmed: 26973801
J Proteomics. 2016 Apr 14;138:106-14
pubmed: 26917472
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):567-582
pubmed: 28296247
Gene Ther. 2003 Jul;10(14):1135-41
pubmed: 12833122
Mol Cell Proteomics. 2009 Jul;8(7):1708-18
pubmed: 19383612
Mol Genet Metab. 2017 Jan - Feb;120(1-2):78-95
pubmed: 27979613
Proteomics Clin Appl. 2019 Jan;13(1):e1700179
pubmed: 30365225
Neurochem Int. 2015 Aug;87:1-12
pubmed: 25958317
Colloids Surf B Biointerfaces. 2019 May 1;177:141-148
pubmed: 30721790
Drug Des Devel Ther. 2015 Apr 01;9:1937-53
pubmed: 25897204
Clin Ther. 2017 Jan;39(1):118-129.e3
pubmed: 27955919
Biochem Soc Trans. 2010 Dec;38(6):1413-6
pubmed: 21118098
JIMD Rep. 2015;15:59-66
pubmed: 24718838
Hum Mol Genet. 1998 Jun;7(6):981-9
pubmed: 9580662
Arthritis Res Ther. 2016 May 04;18(1):98
pubmed: 27146865
J Mol Cell Biol. 2013 Aug;5(4):214-26
pubmed: 23918283
Exp Eye Res. 2019 Jan;178:247-254
pubmed: 30114413
Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):81-89
pubmed: 30587502
Drugs. 2019 Jul;79(10):1103-1134
pubmed: 31209777
Proteomics. 2019 Jan;19(1-2):e1800164
pubmed: 30536821
Expert Rev Proteomics. 2017 May;14(5):419-429
pubmed: 28436239
BMC Bioinformatics. 2012;13 Suppl 16:S5
pubmed: 23176322
Theranostics. 2017 Sep 26;7(18):4350-4358
pubmed: 29158831
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Data Brief. 2018 Feb 27;18:1-8
pubmed: 29896482
Anal Chem. 1996 Mar 1;68(5):850-8
pubmed: 8779443
J Cell Physiol. 2019 Jul;234(7):10512-10522
pubmed: 30480808
Mol Genet Metab. 2016 Feb;117(2):150-6
pubmed: 26432669
J Biol Chem. 2013 Apr 26;288(17):11649-61
pubmed: 23463506
J Proteomics. 2018 Mar 20;175:105-113
pubmed: 29317355
Gene Ther. 2003 Jul;10(14):1142-51
pubmed: 12833123
Front Physiol. 2017 Jan 20;8:5
pubmed: 28163686
Proteomics. 2018 Apr;18(8):e1700242
pubmed: 29460479
J Cell Biol. 2016 Sep 26;214(7):831-45
pubmed: 27646275
Anal Chim Acta. 2017 Apr 29;964:7-23
pubmed: 28351641
Front Cell Dev Biol. 2017 Dec 07;5:106
pubmed: 29270406
Curr Med Chem. 2007;14(28):2945-53
pubmed: 18220730
Curr Gene Ther. 2005 Jun;5(3):299-310
pubmed: 15975007
J Proteomics. 2010 Oct 10;73(11):2064-77
pubmed: 20685252
Curr Opin Biotechnol. 2001 Oct;12(5):461-6
pubmed: 11604321
J Inherit Metab Dis. 2007 Apr;30(2):165-74
pubmed: 17347914

Auteurs

J Víctor Álvarez (JV)

Department of Pharmacology, Pharmacy and Pharmaceutical Technology, School of Pharmacy, Campus Vida, University of Santiago de Compostela, 15872 Santiago de Compostela, Spain. josevictor.Alvarezgonzalez@nemours.org.
Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, MetabERN, 15706 Santiago de Compostela, Spain. josevictor.Alvarezgonzalez@nemours.org.
Skeletal Dysplasia Lab Nemours Biomedical Research Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA. josevictor.Alvarezgonzalez@nemours.org.

Susana B Bravo (SB)

Proteomic Platform, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostea, Spain. sbbravo@gmail.com.

María García-Vence (M)

Proteomic Platform, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostea, Spain. mariagarve@outlook.es.

María J De Castro (MJ)

Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, MetabERN, 15706 Santiago de Compostela, Spain. mj.decastrol@gmail.com.

Asteria Luzardo (A)

Department of Pharmacology, Pharmacy and Pharmaceutical Technology, School of Sciences, Campus de Lugo, University of Santiago de Compostela, 27002 Lugo, Spain. asteriam.luzardo@usc.es.
Paraquasil Platform, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain. asteriam.luzardo@usc.es.

Cristóbal Colón (C)

Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, MetabERN, 15706 Santiago de Compostela, Spain. cristobal.colon.mejeras@sergas.es.

Shunji Tomatsu (S)

Skeletal Dysplasia Lab Nemours Biomedical Research Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA. shunji.tomatsu@nemours.org.

Francisco J Otero-Espinar (FJ)

Department of Pharmacology, Pharmacy and Pharmaceutical Technology, School of Pharmacy, Campus Vida, University of Santiago de Compostela, 15872 Santiago de Compostela, Spain. francisco.otero@usc.es.
Paraquasil Platform, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain. francisco.otero@usc.es.

María L Couce (ML)

Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, MetabERN, 15706 Santiago de Compostela, Spain. mariluz.couce@usc.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH